BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated July 19, 2021, titled "Balaxi Pharmaceuticals further diversifies geographical mix, reports 23% YoY increase in Profit After Tax for Q1FY22".
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated July 19, 2021, titled "Balaxi Pharmaceuticals further diversifies geographical mix, reports 23% YoY increase in Profit After Tax for Q1FY22".